论文部分内容阅读
近年临床研究表明,大部分白血病和淋巴瘤存在某种染色体易位,易位会产生新的融合基因。这些标志可以用于诊断不同类型的白血病和淋巴瘤。世界卫生组织 2000年发布的白血病和淋巴瘤诊断标准已经将染色体易位作为最重要的指标之一 [1]。当前白血病和淋巴瘤的治疗取得了很大进
In recent years, clinical studies have shown that most leukemias and lymphomas have some chromosomal translocations and translocations produce new fusion genes. These markers can be used to diagnose different types of leukemias and lymphomas. The diagnostic criteria for leukemia and lymphoma released by the World Health Organization in 2000 have made chromosomal translocation one of the most important indicators [1]. The current treatment of leukemia and lymphoma has made great progress